ERIC NGO: Open Payments
NPI 1942658059 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 61 payments from 24 companies in 2025. Trend: 2023 $877 · 2024 $1,897 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $339 |
| Medtronic, Inc. | 8 | $262 |
| Lilly USA, LLC | 7 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| ABBVIE INC. | 4 | $88 |
| Eisai Inc. | 3 | $86 |
| Tonix Medicines, Inc. | 1 | $84 |
| ARGENX US, INC. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Impel Pharmaceuticals LLC | 2 | $46 |
Products named: Briviact, INCEPTIV, AMYVID, HYQVIA, BOTOX, Leqembi, VYVGART HYTRULO, Fintepla.
Industry payments across TX — which companies pay providers there.
